16+
Medicine September 14, 2020

Eight months of COVID-19 in Africa

Возможно, это изображение (текст «COVID-19 IN AFRICA Central Africa 4.2% Western Africa 12.5% Eastern Africa 12.5% 1,353,283 cases Southern Africa 52% Northern Africa 20.1% Source: African Centre for Disease Control and Preventi on, asofSeptember INTEXPERTISE»)

Since February 14, when the first case in Africa was diagnosed, the African Centre for Disease Control and Prevention has recorded 1,353,283 confirmed cases of COVID-19, 80% of which are marked as successful recoveries and 2.6% (32,625) as deaths.

More than half of all the cases have been recorded in Southern Africa (703k) and South Africa in particular (650k). However, in regard to the case fatality rate (CFR), the leader is Chad (7.4%) whereas South Africa has only 2.4%, which is even below the global average (3.2%). It may be noted that formally the leader by CFR in Africa is Western Sahara (8%), but these numbers are inaccurate as data is only available only for the Sahrawi Arab Democratic Republic controlled land, which is approximately 20% of the whole territory.

More than half of all the cases have been recorded in Southern Africa (703k) and South Africa in particular (650k). However, in regard to the case fatality rate (CFR), the leader is Chad (7.4%) whereas South Africa has only 2.4%, which is even below the global average (3.2%).

South Africa also remains on top in terms of COVID-19 prevalence rates: the number of cases per 100k population is 1,118. The second is Cabo Verde (802) while Djibouti (540) takes the third place. The average rate for Africa is 100.

No deaths have been registered in Eritrea, and Burundi has recorded only 1 death out of 471 cases.

As far as treatment is concerned, Russia is studying options for exporting its Sputnik-V vaccine to Egypt and some other African states, starting from as soon as November or December, — as the head of the Russian Direct Investment Fund Kirill Dmitriev told at the press conference on August, 20. So far, Nigeria has been reported to receive vaccine samples in order to conduct its own research.

Print